{"entity":{"type":"insider","cik":"0001861464","url":"/insider/0001861464","json_url":"/insider/0001861464.json","name":"Worthington Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2022-06-24","last":"2026-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Worthington Mark","source":"filing","n_filings":8,"first_seen":"2022-06-24","last_seen":"2026-03-05"}],"transactions":[{"id":6009267,"accession":"0001861464-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001861464-26-000004","line_url":"/filing/0001861464-26-000004#line-2","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"LeonaBio, Inc.","issuer_ticker":"LONA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (GENERAL COUNSEL and CCO)","role_mark":"O","role_mark_label":"Officer (GENERAL COUNSEL and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GENERAL COUNSEL and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1328.0,"shares_display":"1,328","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":7131.36,"total_display":"7,131.36","total_whole":"7,131","shares_owned_after":18376.0,"shares_owned_after_display":"18,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":6082783,"accession":"0001861464-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001861464-26-000002","line_url":"/filing/0001861464-26-000002#line-2","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":876.0,"shares_display":"876","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":6026.88,"total_display":"6,026.88","total_whole":"6,027","shares_owned_after":13978.0,"shares_owned_after_display":"13,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-05","scope":"insider"},{"id":4358626,"accession":"0001415889-25-019066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019066","line_url":"/filing/0001415889-25-019066#line-2","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8526.0,"shares_display":"8,526","price_per_share":0.2935,"price_display":"0.29","price_state":"stated","total_value":2502.381,"total_display":"2,502.38","total_whole":"2,502","shares_owned_after":111875.0,"shares_owned_after_display":"111,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-02","scope":"insider"},{"id":4174531,"accession":"0001415889-25-000525","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-000525","line_url":"/filing/0001415889-25-000525#line-3","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8510.0,"shares_display":"8,510","price_per_share":0.5619,"price_display":"0.56","price_state":"stated","total_value":4781.769,"total_display":"4,781.77","total_whole":"4,782","shares_owned_after":83735.0,"shares_owned_after_display":"83,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-03","scope":"insider"},{"id":3054856,"accession":"0001415889-24-022984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-022984","line_url":"/filing/0001415889-24-022984#line-3","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2525.0,"shares_display":"2,525","price_per_share":0.566,"price_display":"0.57","price_state":"stated","total_value":1429.15,"total_display":"1,429.15","total_whole":"1,429","shares_owned_after":51927.0,"shares_owned_after_display":"51,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-05","filed_date":"2024-09-05","scope":"insider"},{"id":9287235,"accession":"0001415889-24-004151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-004151","line_url":"/filing/0001415889-24-004151#line-1","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2412.0,"shares_display":"2,412","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":7018.92,"total_display":"7,018.92","total_whole":"7,019","shares_owned_after":34452.0,"shares_owned_after_display":"34,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-02-16","scope":"insider"},{"id":2726570,"accession":"0001209191-24-001145","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-001145","line_url":"/filing/0001209191-24-001145#line-3","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2412.0,"shares_display":"2,412","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":7018.92,"total_display":"7,018.92","total_whole":"7,019","shares_owned_after":34452.0,"shares_owned_after_display":"34,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-08","scope":"insider"},{"id":6184895,"accession":"0001209191-22-039344","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-039344","line_url":"/filing/0001209191-22-039344#line-3","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001861464","owner_name":"Worthington Mark","owner_display_name":"Worthington Mark","owner_url":"/insider/0001861464","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2614.0,"shares_display":"2,614","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":7031.66,"total_display":"7,031.66","total_whole":"7,032","shares_owned_after":19097.0,"shares_owned_after_display":"19,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001620463","name":"LeonaBio, Inc.","url":"/issuer/0001620463","role":"Officer (GENERAL COUNSEL and CCO)","n_filings":8,"first_seen":"2022-06-24","last_seen":"2026-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861464","retrieved_at":"2026-08-22T21:53:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}